Follow-up of pain processing recovery after ketamine in hyperalgesic fibromyalgia patients using brain perfusion ECD-SPECT

  • Eric GuedjEmail author
  • Serge Cammilleri
  • Cécile Colavolpe
  • Catherine de Laforte
  • Jean Niboyet
  • Olivier Mundler
Short communication



The aim of this study was to determine whether the follow-up of pain processing recovery in hyperalgesic fibromyalgia (FM) could be objectively evaluated with brain perfusion ethyl cysteinate dimer single photon computerized tomography (ECD-SPECT) after administration of ketamine.

Materials and methods

We enrolled 17 hyperalgesic FM women patients (48.5 ± 11 years, range 25–63). After treatment with subcutaneous ketamine, 11 patients were considered as “good responders”, with a decrease in pain intensity, evaluated by visual analog scale (VAS), greater than 50%. On the other hand, six patients were considered as “poor responders”. A voxel-based analysis of regional cerebral blood flow (rCBF) was conducted (p voxel < 0.001uc), in the two subgroups of patients, before and after treatment, in comparison to a group of ten healthy subjects, matched for age and gender.


In comparison to baseline brain SPECT, midbrain rCBF showed a greater increase after ketamine in the responder group than in the nonresponder group (p cluster = 0.016c). In agreement with the clinical response, the change in midbrain rCBF after ketamine was highly correlated with the reduction of VAS pain score (r = 0.7182; p = 0.0041).


This prospective study suggests that blockade of facilitatory descending modulation of pain with ketamine can be evaluated in the periaqueductal grey with brain perfusion SPECT.


Brain SPECT Voxel-based analysis Pain Fibromyalgia Ketamine 


  1. 1.
    Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–72.PubMedCrossRefGoogle Scholar
  2. 2.
    Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesth Analg 2003;97:1730–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Guedj E, Taieb D, Cammilleri S, Lussato D, de Laforte C, Niboyet J, et al. 99mTc-ECD brain perfusion SPECT in hyperalgesic fibromyalgia. Eur J Nucl Med Mol Imaging 2007;34:130–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Guedj E, Cammilleri S, Colavolpe C, Taieb D, de Laforte C, Niboyet J, et al. Predictive value of brain perfusion SPECT for ketamine response in hyperalgesic fibromyalgia. Eur J Nucl Med Mol Imaging 2007; 34(8):1274–79.PubMedCrossRefGoogle Scholar
  5. 5.
    Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 2004;50:613–23.PubMedCrossRefGoogle Scholar
  6. 6.
    Adiguzel O, Kaptanoglu E, Turgut B, Nacitarhan V. The possible effect of clinical recovery on regional cerebral blood flow deficits in fibromyalgia: a prospective study with semiquantitative SPECT. South Med J 2004;97:651–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Zhang L, Zhang Y, Zhao ZQ. Anterior cingulate cortex contributes to the descending facilitatory modulation of pain via dorsal reticular nucleus. Eur J Neurosci 2005;22:1141–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Lee BH, Park SH, Won R, Park YG, Sohn JH. Antiallodynic effects produced by stimulation of the periaqueductal gray matter in a rat model of neuropathic pain. Neurosci Lett 2000;291:29–32 (Sep 8).PubMedCrossRefGoogle Scholar
  9. 9.
    Langsjo JW, Salmi E, Kaisti KK, Aalto S, Hinkka S, Aantaa R, et al. Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans. Anesthesiology 2004;100:1065–71.PubMedCrossRefGoogle Scholar
  10. 10.
    Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46:1333–43.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Eric Guedj
    • 1
    Email author
  • Serge Cammilleri
    • 1
  • Cécile Colavolpe
    • 1
  • Catherine de Laforte
    • 1
  • Jean Niboyet
    • 2
  • Olivier Mundler
    • 1
  1. 1.Service Central de Biophysique et de Médecine NucléaireAssistance Publique des Hôpitaux de Marseille, Centre Hospitalo-Universitaire de la TimoneMarseilleFrance
  2. 2.Unité d’Etude et de Traitement de la DouleurClinique La PhocéanneMarseilleFrance

Personalised recommendations